Aurora Cannabis Inc.

ACB Healthcare Drug Manufacturers Specialty & Generic

Aurora Cannabis Inc.’s revenue for fiscal 2026 (year ended March 2026) was $232.0 million, down 5.95% from fiscal 2025. In the quarter to June 2026, revenue fell 31.2%, EPS grew 75.0%, free cash flow fell 293.6% and total debt fell 82.5%, each against the same quarter a year earlier.

3.99 0.11 −2.68%
Market cap
$265.8M
P/E
0.0×
Fwd P/E
−783×
Dividend yield
—
F-score
4/9
Altman Z
−12.34
Beneish M
−2.53
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
0.82 0.80 0.90 1.28
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(53.59) (733.60) 19.22 (11.49)
P/B ratio
0.45 0.50 0.59 0.82
Price to Tangible BV
0.51 0.56 0.66 0.92
EV/Sales
0.58 0.53 0.74 1.15
EV/EBITDA
0.00 0.00 0.00 0.00
EV/Operating CF
(5.95) (12.65) (28.81) 185.39
EV/FCF
(3.35) (4.89) (9.25) (25.01)
Quick Ratio
2.59 3.13 1.36 1.52
Current Ratio
5.36 5.94 3.06 3.41
Net Debt/EBITDA
34.68 13.80 (9.14) 4.15
Debt/Assets
2.71% 3.02% 12.25% 12.52%
Debt/Equity
0.03 0.04 0.17 0.17
Asset Turnover
0.40 0.44 0.46 0.46
Operating CF/Net income
1.10 0.01 9.54 0.78
Capex/Depreciation
(1.10) 8.65 (1.22) (0.78)
Interest Coverage
(18.82) 2.33 1.04 (8.37)
Research and Development Expense of Revenue
3.75% 2.57% 1.38% 1.00%
Selling, General and Administrative Expense of Revenue
60.52% 107.67% 42.54% 51.75%
Intangible Assets out of Total Assets
0.10 0.10 0.08 0.08
Share Based Compensation of Revenue
1.03% (5.37%) 2.35% 5.51%
Graham Net Nets
1.26 1.20 0.71 0.51
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
(50.54%) (47.71%) (25.59%) (11.58%)
Free Cash Flow Yield
(20.98%) (13.64%) (8.89%) (3.59%)
Revenue per Share
0.79 0.49 1.19 1.16
Operating CF per Share
(0.05) 0.00 0.22 (0.52)
Capex per Share
(0.06) (0.07) (0.07) (0.07)
Free Cash Flow per Share
(0.12) (0.08) 0.15 (0.59)
Cash per Share
1.75 2.10 1.95 1.83
Shareholders Equity per Share
6.17 6.53 7.18 7.29
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
6.17 6.53 7.18 7.29
Free Cash Flow
(7.12) (4.28) 8.67 (33.37)
Working Capital
231.15 239.23 215.12 217.57
Capital Expenditures
(3.91) (4.03) (3.78) (4.08)
Net Current Asset Value
216.48 223.07 170.98 169.92
EV/EBIT
0.00 0.00 0.00 0.00
Capex to Sales
0.08 0.14 0.06 0.06
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Receivables
28.99 31.39 33.53 31.68
Average Payables
49.91 44.76 49.38 32.22
Average Inventory
150.25 149.28 173.40 158.33
Average Assets
527.11 523.94 587.49 571.12
Average Common Equity
403.18 403.93 422.34 419.49

Fold the line items

Columns are period end dates